Unhealthy Alcohol Use Tools & Resources

Randomized trial of a relational agent-based intervention for alcohol use disorder (AUD), showing that technology can be leveraged to deliver screening and referral to treatment for AUD in primary care medical settings

Acknowledges the link between childhood trauma and substance use disorders; offers information to providers on how to use a trauma-informed care approach while delivering brief intervention

Suggests that alcohol use treatment for patients with alcohol-related cirrhosis of the liver, such as counseling and medication-assisted therapies, can improve outcomes and are cost-effective

Provides an overview of disulfiram for alcohol use, including indications, mechanism of action, administration, adverse effects, contraindications, and how to use it within an interprofessional health care team

Reviews seven trials on naltrexone use for alcohol use disorder, finding that it reduces drinking days and heavy drinking days per month, with longer duration of treatment associated with larger reductions

Systematic review looking at the effects of brief interventions for substance use delivered in general medical settings, finding that alcohol-targeted brief interventions may produce small reductions in drinking

Evalutes the prescene of "spin," a biased way of reporting results, in the abstract of systematic reviews of pharmacotherapy for alcohol use disorder, finding "spin" in more than 40% of the abstracts identified, something physicians should be aware of

Reviews current evidence for the use of screening, brief intervention, and referral (SBIRT) to treatment delivered through mHealth technologies and explores implications of using mHealth to address alcohol use among pregnant and post-partum women

Systematic review of studies identifying barriers and facilitators that influence implementation of screening and brief intervention for alcohol use in primary care settings

Systematic review exploring barriers for using medications for alcohol use disorder in outpatient clinical settings, showing that providers continue to lack knowledge about the use of medications and continue to experience stigma and barriers related to accessing medications